Heterozygous p53(V172F) mutation in cisplatin-resistant human tumor cells promotes MDM4 recruitment and decreases stability and transactivity of p53

por Xie, Xiaolei, Lozano, Guillermina, Siddik, Zahid H.
Publicado 2016

Drug-dependent functionalization of wild-type and mutant p53 in cisplatin-resistant human ovarian tum3or cells

por Bhatt, Michelle, Ivan, Cristina, Xie, Xiaolei, Siddik, Zahid H.
Publicado 2016

Curcumin-Free Turmeric Exhibits Activity against Human HCT-116 Colon Tumor Xenograft: Comparison with Curcumin and Whole Turmeric

por Prasad, Sahdeo, Tyagi, Amit K., Siddik, Zahid H., Aggarwal, Bharat B.
Publicado 2017

New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status

por Altaf, Muhammad, Monim-ul-Mehboob, Muhammad, Kawde, Abdel-Nasser, Corona, Giuseppe, Larcher, Roberto, Ogasawara, Marcia, Casagrande, Naike, Celegato, Marta, Borghese, Cinzia, Siddik, Zahid H., Aldinucci, Donatella, Isab, Anvarhusein A.
Publicado 2016

Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy

por Tsimberidou, Apostolia M, Said, Rabih, Culotta, Kirk, Wistuba, Ignacio, Jelinek, Jaroslav, Fu, Siqing, Falchook, Gerald, Naing, Aung, Piha-Paul, Sarina, Zinner, Ralph, Siddik, Zahid H, He, Guangan, Hess, Kenneth, Stewart, David J, Kurzrock, Razelle, Issa, Jean-Pierre J
Publicado 2015

PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis

por Rodriguez-Aguayo, Cristian, Bayraktar, Emine, Ivan, Cristina, Aslan, Burcu, Mai, Junhua, He, Guangan, Mangala, Lingegowda S., Jiang, Dahai, Nagaraja, Archana S., Ozpolat, Bulent, Chavez-Reyes, Arturo, Ferrari, Mauro, Mitra, Rahul, Siddik, Zahid H., Shen, Haifa, Yang, Xianbin, Sood, Anil K., Lopez-Berestein, Gabriel
Publicado 2019

Corrigendum to “PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis” [EBioMedicine 40 (2019) 290-...

por Rodriguez-Aguayo, Cristian, Bayraktar, Emine, Ivan, Cristina, Aslan, Burcu, Mai, Junhua, He, Guangan, Mangala, Lingegowda S., Jiang, Dahai, Nagaraja, Archana S., Ozpolat, Bulent, Chavez-Reyes, Arturo, Ferrari, Mauro, Mitra, Rahul, Siddik, Zahid H., Shen, Haifa, Yang, Xianbin, Sood, Anil K., Lopez-Berestein, Gabriel
Publicado 2022